Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 16 | 2022 | 3415 | 1.000 |
Why?
|
Schools, Nursing | 1 | 2024 | 4 | 0.930 |
Why?
|
Hypoglycemic Agents | 13 | 2024 | 3085 | 0.730 |
Why?
|
Clinical Nursing Research | 2 | 2012 | 14 | 0.720 |
Why?
|
Taurine | 2 | 2019 | 93 | 0.720 |
Why?
|
Diabetes Mellitus, Type 2 | 20 | 2024 | 12142 | 0.710 |
Why?
|
Research Personnel | 2 | 2017 | 588 | 0.680 |
Why?
|
Blood Glucose | 18 | 2024 | 6390 | 0.630 |
Why?
|
Ethics, Nursing | 1 | 2017 | 24 | 0.570 |
Why?
|
Codon, Terminator | 1 | 2017 | 124 | 0.550 |
Why?
|
Metformin | 6 | 2024 | 906 | 0.420 |
Why?
|
Legal Guardians | 1 | 2012 | 57 | 0.410 |
Why?
|
Third-Party Consent | 1 | 2012 | 66 | 0.410 |
Why?
|
Blood Glucose Self-Monitoring | 5 | 2024 | 467 | 0.410 |
Why?
|
Diabetic Angiopathies | 2 | 2014 | 803 | 0.390 |
Why?
|
Diabetes Complications | 5 | 2022 | 1315 | 0.370 |
Why?
|
Community-Based Participatory Research | 1 | 2012 | 220 | 0.350 |
Why?
|
Joint Diseases | 1 | 2014 | 459 | 0.340 |
Why?
|
Protein Biosynthesis | 1 | 2017 | 2100 | 0.340 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10199 | 0.340 |
Why?
|
Professional Role | 1 | 2012 | 313 | 0.330 |
Why?
|
Insulin | 10 | 2024 | 6593 | 0.330 |
Why?
|
Sulfonylurea Compounds | 4 | 2024 | 219 | 0.320 |
Why?
|
Multicenter Studies as Topic | 2 | 2014 | 1700 | 0.300 |
Why?
|
Musculoskeletal Diseases | 1 | 2014 | 597 | 0.300 |
Why?
|
Models, Nursing | 1 | 2007 | 46 | 0.290 |
Why?
|
Nursing Research | 1 | 2007 | 80 | 0.280 |
Why?
|
Injections, Subcutaneous | 2 | 2008 | 671 | 0.280 |
Why?
|
Zebrafish | 1 | 2017 | 3007 | 0.250 |
Why?
|
Nursing Staff, Hospital | 1 | 2007 | 348 | 0.230 |
Why?
|
Gender Identity | 1 | 2010 | 765 | 0.230 |
Why?
|
Education, Nursing | 1 | 2024 | 80 | 0.220 |
Why?
|
Insulin Resistance | 2 | 2023 | 3954 | 0.200 |
Why?
|
Self Care | 3 | 2019 | 796 | 0.200 |
Why?
|
Hyperglycemia | 3 | 2022 | 1375 | 0.190 |
Why?
|
History, 19th Century | 1 | 2024 | 718 | 0.190 |
Why?
|
Boston | 3 | 2024 | 9313 | 0.190 |
Why?
|
Benchmarking | 1 | 2007 | 1045 | 0.180 |
Why?
|
Glucose | 1 | 2012 | 4345 | 0.180 |
Why?
|
Bass | 1 | 2019 | 7 | 0.170 |
Why?
|
Attitude to Health | 1 | 2008 | 2024 | 0.160 |
Why?
|
Hospitals, General | 4 | 2012 | 798 | 0.160 |
Why?
|
Intensive Care Units | 1 | 2012 | 3742 | 0.160 |
Why?
|
Cysteic Acid | 1 | 2017 | 2 | 0.150 |
Why?
|
Carboxy-Lyases | 1 | 2017 | 85 | 0.140 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15498 | 0.140 |
Why?
|
Biomedical Research | 1 | 2012 | 3426 | 0.140 |
Why?
|
Pamphlets | 1 | 2017 | 71 | 0.140 |
Why?
|
Vision, Ocular | 1 | 2019 | 454 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2764 | 0.130 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3680 | 0.130 |
Why?
|
Coronary Disease | 1 | 2010 | 5912 | 0.130 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5835 | 0.120 |
Why?
|
Lost to Follow-Up | 1 | 2015 | 123 | 0.120 |
Why?
|
Patient Advocacy | 1 | 2017 | 360 | 0.120 |
Why?
|
Hearing Loss | 2 | 2019 | 781 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3351 | 0.120 |
Why?
|
Humans | 43 | 2024 | 760617 | 0.110 |
Why?
|
Gastroparesis | 1 | 2015 | 138 | 0.110 |
Why?
|
Gastric Emptying | 1 | 2015 | 243 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2017 | 4007 | 0.100 |
Why?
|
Hashimoto Disease | 1 | 2014 | 107 | 0.100 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1285 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1595 | 0.100 |
Why?
|
Erectile Dysfunction | 1 | 2015 | 444 | 0.100 |
Why?
|
Middle Aged | 22 | 2024 | 220584 | 0.100 |
Why?
|
Amino Acids | 1 | 2017 | 1717 | 0.090 |
Why?
|
Adolescent Health Services | 1 | 2013 | 218 | 0.090 |
Why?
|
Massachusetts | 4 | 2012 | 8833 | 0.090 |
Why?
|
Inpatients | 2 | 2012 | 2544 | 0.090 |
Why?
|
Comparative Effectiveness Research | 3 | 2022 | 708 | 0.090 |
Why?
|
Adult | 19 | 2024 | 220969 | 0.090 |
Why?
|
Career Mobility | 1 | 2012 | 259 | 0.090 |
Why?
|
Male | 28 | 2024 | 360358 | 0.090 |
Why?
|
Needs Assessment | 2 | 2013 | 1139 | 0.080 |
Why?
|
Female | 29 | 2024 | 392148 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2017 | 2697 | 0.080 |
Why?
|
Automation | 1 | 2012 | 585 | 0.080 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2315 | 0.080 |
Why?
|
Patient Compliance | 3 | 2019 | 2688 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39063 | 0.080 |
Why?
|
Prediabetic State | 1 | 2014 | 545 | 0.080 |
Why?
|
Job Satisfaction | 1 | 2012 | 544 | 0.080 |
Why?
|
Nursing Evaluation Research | 1 | 2007 | 25 | 0.080 |
Why?
|
Lipids | 3 | 2021 | 3332 | 0.070 |
Why?
|
Nursing Methodology Research | 1 | 2007 | 64 | 0.070 |
Why?
|
Diabetic Retinopathy | 2 | 2015 | 1273 | 0.070 |
Why?
|
Education, Nursing, Continuing | 1 | 2007 | 69 | 0.070 |
Why?
|
Risk Factors | 9 | 2022 | 74115 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2022 | 6305 | 0.070 |
Why?
|
Blood Pressure | 5 | 2021 | 8472 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26049 | 0.070 |
Why?
|
Cohort Studies | 6 | 2022 | 41457 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2014 | 1835 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1437 | 0.070 |
Why?
|
Health Education | 1 | 2013 | 1049 | 0.070 |
Why?
|
Qualitative Research | 1 | 2017 | 3016 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 1066 | 0.060 |
Why?
|
Aged | 11 | 2024 | 169042 | 0.060 |
Why?
|
Menopause | 1 | 2013 | 1645 | 0.060 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 13441 | 0.060 |
Why?
|
Prevalence | 3 | 2020 | 15689 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8529 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2015 | 14591 | 0.060 |
Why?
|
Adolescent Behavior | 1 | 2013 | 1187 | 0.060 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2022 | 311 | 0.060 |
Why?
|
Cholesterol, LDL | 2 | 2010 | 2379 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 6174 | 0.050 |
Why?
|
Cognition | 3 | 2023 | 6987 | 0.050 |
Why?
|
Leadership | 1 | 2012 | 1385 | 0.050 |
Why?
|
Diffusion of Innovation | 1 | 2007 | 729 | 0.050 |
Why?
|
Safety Management | 1 | 2007 | 760 | 0.050 |
Why?
|
Calibration | 1 | 2024 | 817 | 0.050 |
Why?
|
Employment | 1 | 2008 | 1113 | 0.050 |
Why?
|
Glucose Tolerance Test | 1 | 2024 | 1178 | 0.050 |
Why?
|
Serum Albumin | 1 | 2024 | 672 | 0.050 |
Why?
|
Triglycerides | 1 | 1988 | 2459 | 0.040 |
Why?
|
Self Report | 1 | 2012 | 3723 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2016 | 0.040 |
Why?
|
Depressive Disorder | 2 | 2015 | 3735 | 0.040 |
Why?
|
Young Adult | 6 | 2022 | 59179 | 0.040 |
Why?
|
Dyslipidemias | 2 | 2022 | 868 | 0.040 |
Why?
|
Sex Factors | 2 | 2014 | 10548 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7995 | 0.040 |
Why?
|
Patient Selection | 1 | 2012 | 4237 | 0.040 |
Why?
|
Patient Discharge | 1 | 2012 | 3442 | 0.040 |
Why?
|
Disease Management | 1 | 2010 | 2506 | 0.040 |
Why?
|
Animal Feed | 1 | 2019 | 112 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2013 | 6224 | 0.040 |
Why?
|
Fisheries | 1 | 2019 | 48 | 0.040 |
Why?
|
Diabetic Neuropathies | 1 | 2022 | 405 | 0.040 |
Why?
|
Albuminuria | 1 | 2022 | 655 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3879 | 0.040 |
Why?
|
Microvessels | 1 | 2022 | 577 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2017 | 58894 | 0.040 |
Why?
|
Adolescent | 8 | 2019 | 88234 | 0.030 |
Why?
|
Quality of Life | 2 | 2015 | 13347 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1810 | 0.030 |
Why?
|
Time Factors | 2 | 2015 | 39913 | 0.030 |
Why?
|
Infusion Pumps, Implantable | 1 | 1996 | 158 | 0.030 |
Why?
|
Body Mass Index | 3 | 2023 | 12943 | 0.030 |
Why?
|
Poverty Areas | 1 | 2015 | 263 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2178 | 0.030 |
Why?
|
Insulin Infusion Systems | 1 | 2015 | 217 | 0.030 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2014 | 101 | 0.030 |
Why?
|
Insulin, Long-Acting | 1 | 2013 | 58 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 636 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1110 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1723 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3302 | 0.020 |
Why?
|
Algorithms | 1 | 2012 | 14018 | 0.020 |
Why?
|
Urinary Incontinence | 1 | 2015 | 489 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3877 | 0.020 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2013 | 364 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7389 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54360 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1370 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2013 | 5491 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2015 | 709 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.020 |
Why?
|
Microcirculation | 1 | 2013 | 1272 | 0.020 |
Why?
|
Hypoglycemia | 1 | 1996 | 883 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168201 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4614 | 0.020 |
Why?
|
Remission Induction | 1 | 2014 | 2391 | 0.020 |
Why?
|
Retina | 1 | 2019 | 2655 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 972 | 0.020 |
Why?
|
Triazoles | 1 | 2013 | 903 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2392 | 0.020 |
Why?
|
Intelligence Tests | 1 | 1988 | 503 | 0.020 |
Why?
|
Pyrazines | 1 | 2013 | 1202 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2012 | 724 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 695 | 0.020 |
Why?
|
Child | 4 | 2019 | 80079 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2012 | 960 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4845 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10704 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12447 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2022 | 64568 | 0.010 |
Why?
|
United States | 3 | 2018 | 72272 | 0.010 |
Why?
|
Social Support | 1 | 2013 | 2174 | 0.010 |
Why?
|
Health Status | 1 | 2015 | 4075 | 0.010 |
Why?
|
Reaction Time | 1 | 1988 | 2087 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9604 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2350 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2682 | 0.010 |
Why?
|
Cholesterol | 1 | 1988 | 2903 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12043 | 0.010 |
Why?
|
Heart Failure | 1 | 2022 | 11669 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22148 | 0.010 |
Why?
|
Exercise | 1 | 2013 | 5886 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1996 | 361 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1996 | 412 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21337 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13245 | 0.010 |
Why?
|
Diet | 1 | 2013 | 8048 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1996 | 2214 | 0.010 |
Why?
|
Eating | 1 | 1996 | 1535 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1996 | 1882 | 0.000 |
Why?
|
Obesity | 1 | 1988 | 12933 | 0.000 |
Why?
|
Concepts
(200)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_